Living with pulmonary artery hypertension: Patients' experiences

被引:48
作者
Flattery, MP
Pinson, JM
Savage, L
Salyer, J
机构
[1] Virginia Commonwealth Univ, Med Ctr, Cardiopulm Transplant Program, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, Richmond, VA 23284 USA
[3] Virginia Commonwealth Univ, Med Ctr, Div Cardiothorac Nursing, Richmond, VA 23284 USA
[4] Virginia Commonwealth Univ, Sch Nursing, Richmond, VA 23284 USA
来源
HEART & LUNG | 2005年 / 34卷 / 02期
关键词
D O I
10.1016/j.hrtlng.2004.06.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Research on the outcomes of medical therapy in persons with pulmonary artery hypertension (PAH) has increased as new therapeutic options have emerged. Little investigation has been done on the impact of living with PAH despite inferences that quality of life (QOL) improves. PURPOSE: The purpose of this qualitative study was to describe patient experiences of living with PAH and identify factors that may have an impact on QOL. PARTICIPANTS: Participants (n = 11; 8 women, 3 men) were selected from among 42 adult patients, 40 to 72 years of age, followed in an outpatient setting at a tertiary care hospital. Multiple types of treatment modalities were represented including calcium channel blockers, endothelin-receptor antagonists, prostacyclin analog, and lung transplantation. METHODS: Semistructured interviews allowed participants to describe experiences living with PAH. Interviews were recorded on audiotape and transcribed verbatim. Analysis was conducted in accordance with Colaizzi's 7-step process for analysis of phenomenologic data. RESULTS: Two overarching themes emerged indicating that participants experience uncertainty associated with a variety of aspects of this illness but also learn to cope with this uncertainty and move on with their lives. IMPLICATIONS: Assisting patients to cope with the uncertainty associated with this chronic health problem is essential if patients are to successfully adjust to the demands of the illness and its treatment. Attention to the findings of this study should guide health care professionals in their efforts to improve QOL in this patient population.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 35 条
[1]  
Albaugh Jeffrey A, 2003, Oncol Nurs Forum, V30, P593, DOI 10.1188/03.ONF.593-598
[2]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[3]   SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN [J].
BARST, RJ ;
RUBIN, LJ ;
MCGOON, MD ;
CALDWELL, EJ ;
LONG, WA ;
LEVY, PS .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :409-415
[4]  
Buelow J M, 1991, J Neurosci Nurs, V23, P247
[5]   Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].
Channick, RN ;
Simonneau, G ;
Sitbon, O ;
Robbins, IM ;
Frost, A ;
Tapson, VF ;
Badesch, DB ;
Roux, S ;
Rainisio, M ;
Bodin, F ;
Rubin, LJ .
LANCET, 2001, 358 (9288) :1119-1123
[6]  
Colaizzi P., 1978, Existential-phenomenological alternatives for psychology
[7]  
Giorgi A., 1985, PHENOMENOLOGY PSYCHO
[8]  
Hildingh C, 2001, Br J Nurs, V10, P1357
[9]   A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group [J].
Howard, MA ;
Duvall, D ;
Terrell, DR ;
Christopher, AT ;
Thomas, I ;
Holloway, N ;
Vesely, SK ;
George, JN .
JOURNAL OF CLINICAL APHERESIS, 2003, 18 (01) :16-20
[10]  
Krempec Jeffrey, 2003, Iowa Orthop J, V23, P80